Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
50.1M
-
Shares change
-
-8.03M
-
Total reported value, excl. options
-
$45.8M
-
Value change
-
-$8.74M
-
Put/Call ratio
-
3.39
-
Number of buys
-
52
-
Number of sells
-
-59
-
Price
-
$0.91
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q1 2025
149 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q1 2025.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.1M shares
of 92.2M outstanding shares and own 54.37% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.35M shares), Pfizer Inc (4.69M shares), VANGUARD GROUP INC (4.52M shares), Kynam Capital Management, LP (3.27M shares), PFM Health Sciences, LP (2.51M shares), Schonfeld Strategic Advisors LLC (2.35M shares), GEODE CAPITAL MANAGEMENT, LLC (2.05M shares), STATE STREET CORP (1.64M shares), TWO SIGMA ADVISERS, LP (1.51M shares), and FMR LLC (1.46M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.